Trials / Withdrawn
WithdrawnNCT04247321
Non-invasive Near-infrared Spectroscopy (NIRS) Versus Invasive Licox Intracranial Pressure
Non-invasive Near-infrared Spectroscopy (NIRS) Versus Invasive Licox Intracranial Pressure Monitoring in Neurocritical Care
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Researchers are trying to assess how accurately and safely NIRS non-invasive monitoring can detect changes in intracranial pressure to determine if this noninvasive device can be used instead of invasive monitoring with Licox in the future.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Licox® Brain Tissue Oxygen Monitoring System | Invasive brain tissue oxygenation monitoring |
| DEVICE | Near-infrared spectroscopy (NIRS) | Non-invasive approach to monitoring brain tissue oxygenation which uses two wavelengths of near infrared light and takes measurements of the ratio of oxyhemoglobin to total hemoglobin |
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
- First posted
- 2020-01-30
- Last updated
- 2021-10-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04247321. Inclusion in this directory is not an endorsement.